Physician profile
David Salek
NPI 1285078832
$24,881.23
in general payments reported to CMS, 2019-2025
49 companies · $2,239 in 2025
The $2,239 reported for 2025 was more than what 80% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,557 · 2020: $4,137 · 2021: $1,919 · 2022: $4,323 · 2023: $2,455 · 2024: $2,251 · 2025: $2,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,282 · Consulting Fee: $555 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,281.92 |
| Consulting Fee | $555.00 |
| Education | $107.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,377.28 | 2019-2025 | Na, Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $6,167.47 | 2019-2024 | Senza |
| Medtronic, INC. | $3,563.47 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $2,547.43 | 2019-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $1,856.60 | 2021-2023 | Intracept |
| Abbvie INC. | $873.39 | 2021-2025 | |
| Globus Medical, INC. | $329.07 | 2025 | Senza |
| Painteq LLC | $300.54 | 2022-2024 | Painteq |
| Stimwave Technologies Incorporated | $291.03 | 2019 | |
| Tersera Therapeutics LLC | $271.18 | 2019-2023 | Prialt |
| Spr Therapeutics, INC | $262.63 | 2022-2025 | Sprint Pns System |
| Allergan, INC. | $220.18 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $199.50 | 2019-2025 | Belbuca |
| Medtronic USA, INC. | $147.01 | 2019-2020 | |
| Carlsmed, INC. | $131.63 | 2025 | Aprevo |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Salek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.